GenBio Inc

Current prescription drugs invariably suffer from significant toxicity issues and other concerns that can seriously impact consumers’ health; cardiovascular and gastrointestinal side effects encountered by the general population are common. There are also increasing worries about antimicrobial resistance. The world is urgently seeking a new class of next-generation anti-inflammatory drugs to combat these growing concerns. GenBio is developing an entirely new class of more potent, yet far less toxic anti-inflammatory drugs, based on a newly discovered and unique new class of molecules. We are the first company in the world to identify, then research a unique rare natural extract showing truly remarkable and unique capabilities to treat a variety of ailments and diseases way more effectively and yet with way fewer side effects